Gina Soto
About Gina Soto
Gina Soto is the District Business Leader at Alkermes in Dublin, Ireland, with extensive experience in pharmaceutical sales and business management.
Current Position
Gina Soto is currently serving as District Business Leader at Alkermes in Dublin, Ireland. In this role, Gina leverages her extensive experience in the healthcare and pharmaceutical sectors to drive business opportunities and develop effective sales strategies. Her leadership plays a key role in shaping the company's market presence in the region.
Previous Roles at Sunovion Pharmaceuticals Inc.
Gina Soto held several significant positions at Sunovion Pharmaceuticals Inc. Between 2013 and 2015, she worked as a Regional Business Manager in Marlborough, Massachusetts. Prior to that, she served as a Special Project Trainer in Sales Training and Development for five months in 2012-2013 and as a Psychiatry Therapeutic Specialist from 2011 to 2012. These roles equipped her with comprehensive skills in sales training, regional business management, and therapeutic specialties.
Career at Pfizer
Gina Soto worked as a Neurology | Psychiatry | MS Therapeutic Specialty Representative at Pfizer from 2004 to 2011 in New York. Her extensive seven-year tenure at Pfizer established her expertise in therapeutic specialties, specifically in neurology and psychiatry. This role laid the foundation for her subsequent career advancements in the pharmaceutical industry.
Educational Background
Gina Soto earned her Bachelor of Science in Biological Science and Chemistry from California State University, Fullerton, where she studied from 1999 to 2003. Her academic background in the sciences has been fundamental to her understanding and success in the pharmaceutical and healthcare sectors.
Expertise and Skills
Gina Soto is recognized for her expertise in the Buy and Bill Model, a key reimbursement strategy for specialty biologics. She is also skilled in using DISC, a behavioral assessment tool, to enhance work productivity and teamwork. Gina employs the Predictive Index for building and leading high-performing teams. Her strategic perspective on public policy initiatives, combined with her ability to cultivate strong cross-functional partnerships, underpins her effectiveness in improving patient access to treatments.
Notable Contributions
Gina Soto led the successful launch of ARISTADA and INITIO, contributing significantly to advancements in psychiatric disorder treatments. Her contributions include shaping national strategies to improve patient access to treatments. Through her strategic initiatives and expertise, she continues to make impactful contributions to the pharmaceutical landscape.